Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport vs Neuronox for Hemifacial Spasm in Thai Patients
NCT04589364Phase 3Completed
- Sponsor
- Ministry of Public Health
- Start
- May 2024
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A, neuronox in hemifacial spasm (HFS), sponsored by Ministry of Public Health. Started May 2024; status: completed.
02
Drugs
botulinum toxin type Aneuronox
03
Conditions
hemifacial spasm (HFS)
Beyond the preview
Go deeper on NCT04589364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589364.